Cell & Gene Therapies: Re-thinking Development & Value Creation

Cell & Gene Therapies: Re-thinking Development & Value Creation

Live Webinar – Cell & Gene Therapies: Rethinking Development & Value Creation

Taking holistic approach to trial design, regulatory pathway, value creation and investment proposition can vastly increase chances of success for the developers of advanced therapies.

Join our live webinar – “Cell & Gene Therapies: Rethinking Development & Value Creation”  presented by Dr. Sven Kili, IAG’s Member of Scientific Advisory board and Cell & Gene Therapy Senior Leader.

Key discussions points:

  • Development of Cell or Gene Therapy
  • Optimising clinical development and study design
  • Regulatory pathways in the EU and USA
  • Value creation and investment proposition

The session will begin with Dr. Kili’s talk and will be followed by a live Q&A to give the audience the opportunity to gain insight into their own development programs.

Date: 7th May 2020

Time: 11am EST / 4pm GMT

Register here!

About the Webinar:

This webinar is organized by IAG, Image Analysis Group, a strategic partner to bio-pharmaceutical companies developing new treatments to improve patients’ lives. IAG broadly leverages its core imaging expertise, proprietary technology platform DYNAMIKA and capabilities to support an objective early go no/ go decision and drive excellence for tomorrow’s innovative therapeutic agents with speed. We fuse decades of therapeutic insights, risk-sharing business model and agile culture to accelerate novel drug development. www.ia-grp.com

Dr. Sven Kili is pharmaceutical physician and clinician, who spent his career on supporting pharma and biotech companies in developing and commercialising innovative advanced therapies. In his talk he will share an insight into ethics, drug development and value creation when it comes to development of novel advanced therapies.

Questions or need help registering, please email <eden.chrifi-alaoui@ia-grp.com>